Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Schematic diagram of the oseltamivir PK model.

More »

Fig 1 Expand

Fig 2.

Flowchart of method used in model fitting.

More »

Fig 2 Expand

Table 1.

OP and OC PK parameters in uninfected ferrets following an oral dose of oseltamivir.a

More »

Table 1 Expand

Fig 3.

Diagnostic plots for the PK model from influenza-inoculated ferret data from studies 1 and 2.

Closed squares and open circles are for animals inoculated with influenza A and influenza B, respectively. Diagnostic plots include (A) predicted versus observed, (B) weighted residuals versus predicted, and (C) weighted residuals versus time since the last dose. The dashed lines are loess curves.

More »

Fig 3 Expand

Fig 4.

Diagnostic plots for the PK model from uninfected ferret data from studies 1 to 3.

Diagnostic plots include (A) predicted versus observed, (B) weighted residuals versus predicted, and (C) weighted residuals versus time since the last dose. The dashed lines are loess curves.

More »

Fig 4 Expand

Fig 5.

Post-hoc fits in representative ferrets.

Observed and simulated OC PK in representative ferrets from studies 1 and 2: (A) rich PK in an H5N1-inoculated ferret administered a 12.5 mg/kg OP dose; (B) rich PK in an uninfected ferret administered a 5.0 mg/kg OP dose; (C) sparse PK in an H5N1-infected ferret administered 25.0 mg/kg OP q12h; (D) sparse PK in an H3N2-infected ferret administered 12.5 mg/kg OP every twelve h (q12h); (E) PK for an uninfected ferret in the PK control group administered 0.76, 3.8, and 19.0 mg/kg OP on days 1, 3, and 5, respectively; and (F) sparse PK in a ferret inoculated with influenza B/Yamagata/16/1988 influenza virus administered 3.8 mg/kg OP q12h.

More »

Fig 5 Expand

Table 2.

Selected PK parameters and clinical signs in ferrets challenged with influenza A viruses (Study 1).

More »

Table 2 Expand

Table 3.

Selected PK parameters and clinical signs in ferret challenged with influenza B virus (Study 2).

More »

Table 3 Expand

Table 4.

OC PK parameters estimated in ferrets with and without anesthesia.

More »

Table 4 Expand

Table 5.

OC PK parameters estimated in uninfected and influenza virus-infected ferrets.

More »

Table 5 Expand

Fig 6.

Monte Carlo simulation of steady-state OC PK at a 5.08 mg/kg OP dose.

The thin solid curves are simulated PK for 100 individual ferrets, the open curves are the 10th–90th percentile, and the thick solid curve is the median OC concentration-time profile.

More »

Fig 6 Expand

Table 6.

Monte Carlo simulation parameters and covariance matrix for the OC PK model.

More »

Table 6 Expand

Table 7.

OC PK parameters estimated from Monte Carlo simulations for ferrets inoculated with influenza A or B viruses.

More »

Table 7 Expand